2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Author:

Ommen Steve R.,Ho Carolyn Y.,Asif Irfan M.1,Balaji Seshadri2,Burke Michael A.,Day Sharlene M.,Dearani Joseph A.,Epps Kelly C.,Evanovich Lauren3,Ferrari Victor A.45,Joglar José A.,Khan Sadiya S.6,Kim Jeffrey J.7,Kittleson Michelle M.4,Krittanawong Chayakrit8,Martinez Matthew W.,Mital Seema,Naidu Srihari S.,Saberi Sara,Semsarian Christopher,Times Sabrina9,Waldman Cynthia Burstein3

Affiliation:

1. AMSSM representative.

2. HRS representative.

3. Lay stakeholder representative.

4. AHA/ACC Joint Committee on Clinical Practice Guidelines liaison.

5. SCMR representative.

6. ACC/AHA Joint Committee on Performance Measures representative.

7. PACES representative.

8. ACC/AHA Joint Committee on Clinical Data Standards representative.

9. Joint ACC/AHA staff representative.

Abstract

AIM: The “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy” provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. METHODS: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE: Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy” have been updated with new evidence to guide clinicians.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference749 articles.

1. Committee on Standards for Developing Trustworthy Clinical Practice Guidelines Institute of Medicine (US). Clinical Practice Guidelines We Can Trust. National Academies Press; 2011.

2. Committee on Standards for Systematic Reviews of Comparative Effectiveness Research Institute of Medicine (US). Finding What Works in Health Care: Standards for Systematic Reviews. National Academies Press; 2011.

3. ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures

4. ACCF/AHA Task Force on Practice Guidelines. Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines. American College of Cardiology and American Heart Association. 2010. Accessed September 23 2023. https://www.acc.org/Guidelines/About-Guidelines-and-Clinical-Documents/Methodology and https://professional.heart.org/-/media/phd-files/guidelines-and-statements/methodology_manual_and_policies_ucm_319826.pdf.

5. Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System

Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3